Hudson Bay Capital Management »

Intra Cellular Therapies shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.9M 80k 73.17
2024-06-30 $7.2M 105k 68.49
2024-03-31 $2.1M 30k 69.20
2023-12-31 $1.8M 25k 71.62
2023-09-30 $1.8M 35k 52.09
2020-06-30 $513k 20k 25.65
2020-03-31 $2.0M 131k 15.37

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices Put Option (AMD)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Alphabet Cap Stk Cl C Put Option (GOOG)
Broadcom Call Option (AVGO)
New York Cmnty Bancorp Com New (NYCB)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Coinbase Global Com Cl A Put Option (COIN)
Dollar Tree Put Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Intra Cellular Therapies

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
Daniel D. Thurber
Invesco
Bellevue Group
State Street Corporation
Franklin Resources
ClearBridge Advisors
Geode Capital Management
Perceptive Advisors
Pictet Asset Management Holding SA
Suvretta Capital Management
Deep Track Capital

View all funds holding Intra Cellular Therapies